Merck & Co. (MRK) Nabs Breakthrough Tag for Ebola Zaire Vaccine From the FDA and PRIME ...

Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920). Full Article http://j.gs/5sTq

Click here to read full article